Vascular protection of salicin on IL-1β-induced endothelial inflammatory response and damages in retinal endothelial cells. Issue 1 (4th December 2019)
- Record Type:
- Journal Article
- Title:
- Vascular protection of salicin on IL-1β-induced endothelial inflammatory response and damages in retinal endothelial cells. Issue 1 (4th December 2019)
- Main Title:
- Vascular protection of salicin on IL-1β-induced endothelial inflammatory response and damages in retinal endothelial cells
- Authors:
- Song, Yu
Tian, Xia
Wang, Xuehong
Feng, Hui - Abstract:
- Abstract: Retinal endothelial cells (RECs) are involved in many ocular diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Salicin is the major ingredient of willow bark extract, and it has been shown to be a potent anti-inflammatory agent. We aim to explore whether salicin has a vascular protective effect in RECs. Our data indicate that the presence of salicin in RECs culture media ameliorates interleukin-1β (IL-1β)-induced cellular reactive oxygen species (ROS) production and NADPH oxidase 4 (NOX-4) expression. At the cellular level, salicin attenuates IL-1β-induced mitochondrial injury as revealed by its preservation on mitochondrial membrane potential (MMP). Furthermore, salicin inhibits IL-1β-induced production of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1), vascular adhesion molecules such as intercellular cell adhesion molecule-1 (iCAM-1) and vascular cell adhesion molecule 1 (VCAM-1), and high-mobility group protein 1 (HMGB-1). On the other hand, salicin recovers IL-1β-induced reduction of endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) release. The presence of salicin significantly reduces the IL-1β-induced release of lactate dehydrogenase (LDH), indicating that it mitigates cytokine caused cytotoxicity. Mechanistically, we show that salicin suppresses IL-1β-induced activation of the nuclear factor-kappa B (NF-κB) signaling asAbstract: Retinal endothelial cells (RECs) are involved in many ocular diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Salicin is the major ingredient of willow bark extract, and it has been shown to be a potent anti-inflammatory agent. We aim to explore whether salicin has a vascular protective effect in RECs. Our data indicate that the presence of salicin in RECs culture media ameliorates interleukin-1β (IL-1β)-induced cellular reactive oxygen species (ROS) production and NADPH oxidase 4 (NOX-4) expression. At the cellular level, salicin attenuates IL-1β-induced mitochondrial injury as revealed by its preservation on mitochondrial membrane potential (MMP). Furthermore, salicin inhibits IL-1β-induced production of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1), vascular adhesion molecules such as intercellular cell adhesion molecule-1 (iCAM-1) and vascular cell adhesion molecule 1 (VCAM-1), and high-mobility group protein 1 (HMGB-1). On the other hand, salicin recovers IL-1β-induced reduction of endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) release. The presence of salicin significantly reduces the IL-1β-induced release of lactate dehydrogenase (LDH), indicating that it mitigates cytokine caused cytotoxicity. Mechanistically, we show that salicin suppresses IL-1β-induced activation of the nuclear factor-kappa B (NF-κB) signaling as revealed by its suppression on nuclear p65 protein and transfected NF-κB promoter. Collectively, our study demonstrates by multiple facets of its mechanisms that salicin is a protective agent in retinal endothelial cells. These results imply its potential use in therapeutic usage of retinal disease. … (more)
- Is Part Of:
- Artificial cells, nanomedicine, and biotechnology. Volume 47:Issue 1(2019)
- Journal:
- Artificial cells, nanomedicine, and biotechnology
- Issue:
- Volume 47:Issue 1(2019)
- Issue Display:
- Volume 47, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 47
- Issue:
- 1
- Issue Sort Value:
- 2019-0047-0001-0000
- Page Start:
- 1995
- Page End:
- 2002
- Publication Date:
- 2019-12-04
- Subjects:
- Retinal endothelial cell (RECs) -- salicin -- IL-1β -- reactive oxygen species (ROS) -- inflammation -- NF-κB
Artificial cells -- Periodicals
Nanotechnology -- Periodicals
Blood substitutes -- Periodicals
Tissue engineering -- Periodicals
Molecules -- Periodicals
Biotechnology -- Periodicals
615.39 - Journal URLs:
- http://informahealthcare.com/loi/abb?open=2012#id_2012 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/21691401.2019.1608220 ↗
- Languages:
- English
- ISSNs:
- 2169-1401
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25787.xml